Nuvectis Pharma (NVCT) Shares Outstanding (2021 - 2026)

Nuvectis Pharma has disclosed Shares Outstanding across 6 years of filings, most recently posting $26.5 million for Q1 2026.

• Shares Outstanding for Q1 2026 came in at $26.5 million, up 12.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $26.5 million (up 12.23% YoY), and the FY2025 annual result was $25.7 million, up 31.71% from the prior year.
• Shares Outstanding came in at $26.5 million for Q1 2026 at Nuvectis Pharma, up from $25.7 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $26.5 million in Q1 2026 to a low of $12.7 million in Q1 2022.
• The 5-year median for Shares Outstanding is $18.4 million (2024), against an average of $19.1 million.
• Across the five-year window, Shares Outstanding surged 226.1% in 2022 and increased 8.87% in 2024, its largest moves.
• Nuvectis Pharma's Shares Outstanding stood at $15.2 million in 2022, then grew by 14.67% to $17.4 million in 2023, then gained by 11.92% to $19.5 million in 2024, then surged by 31.71% to $25.7 million in 2025, then climbed by 3.31% to $26.5 million in 2026.
• The last three Shares Outstanding figures came in at $26.5 million (Q1 2026), $25.7 million (Q4 2025), and $25.6 million (Q3 2025), per Business Quant data.